We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+10.01%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$466M
AUM Growth
-$255M
Cap. Flow
-$296M
Cap. Flow %
-63.44%
Top 10 Hldgs %
56.9%
Holding
92
New
18
Increased
13
Reduced
21
Closed
28

Top Buys

Rank Stock Value
1
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$9.79M
2
FIVN icon
FIVE9
FIVN
+$5.96M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$5.67M
4
GNRC icon
Generac Holdings
GNRC
+$5.66M
5
ATXS
Astria Therapeutics
ATXS
+$4.84M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$41.8M
2
AZN icon
AstraZeneca
AZN
+$31.2M
3
SNY icon
Sanofi
SNY
+$28.8M
4
NVO
Novo Nordisk
NVO
+$26.4M
5
MRK icon
Merck
MRK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 60.42%
2 Technology 2.22%
3 Industrials 2%
4 Communication Services 0.09%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INFI
51
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$819K 0.18%
1,476,000
– –
TBLA icon
52
Taboola.com
TBLA
$1.37B
$370K 0.08%
+120,000
New +$255K
MGIC
53
DELISTED
Magic Software Enterprises
MGIC
$352K 0.08%
21,981
-59,312
-73% -$944K
IMTXW
54
DELISTED
Immatics N.V. Warrants
IMTXW
$251K 0.05%
100,000
– –
SYRE icon
55
Spyre Therapeutics
SYRE
$8.54B
$198K 0.04%
+17,633
New +$317K
BGMS
56
Bio Green Med Solution Inc
BGMS
$4.91M
$167K 0.04%
69
– –
OTMO
57
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$159K 0.03%
26,124
– –
ARBE icon
58
Arbe Robotics
ARBE
$80.3M
$147K 0.03%
43,165
– –
ONCR
59
DELISTED
Oncorus, Inc.
ONCR
$137K 0.03%
540,258
– –
DYN icon
60
Dyne Therapeutics
DYN
$4.7B
$82.9K 0.02%
+7,149
New +$82.7K
ETNB
61
CALL
DELISTED
89bio
ETNB
$45.8K 0.01%
+3,600
New +$32.4K
TEAD
62
Teads Holding Co
TEAD
$68.7M
$44K 0.01%
+12,148
New +$47.6K
ADBE icon
63
Adobe
ADBE
$99.5B
– –
-29,150
Closed -$8.02M
ALT icon
64
PUT
Altimmune
ALT
$552M
– –
-100,000
Closed -$1.28M
EWTX icon
65
Edgewise Therapeutics
EWTX
$4.13B
– –
-60,000
Closed -$590K
GILD icon
66
Gilead Sciences
GILD
$162B
– –
-105,090
Closed -$6.48M
GLBE icon
67
Global E Online
GLBE
$6.6B
– –
-311,460
Closed -$8.34M
GNRC icon
68
CALL
Generac Holdings
GNRC
$11.6B
– –
-35,600
Closed -$6.34M
ICL icon
69
ICL Group
ICL
$6.53B
– –
-111,482
Closed -$912K
KRNT icon
70
Kornit Digital
KRNT
$705M
– –
-322,926
Closed -$8.59M
NICE icon
71
Nice
NICE
$5.79B
– –
-3,145
Closed -$592K
NVDA icon
72
CALL
NVIDIA
NVDA
$4.86T
– –
-1,726,000
Closed -$21M
NVDA icon
73
NVIDIA
NVDA
$4.86T
– –
-400,000
Closed -$4.86M
PANW icon
74
Palo Alto Networks
PANW
$270B
– –
-126,000
Closed -$10.3M
PERI icon
75
Perion Network
PERI
$375M
– –
-405,184
Closed -$7.82M
1 2
3
4

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2022 Portfolio in Review

As of Q4 2022, Sphera Funds Management held 92 positions worth $466M, down 35% from $720M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sphera Funds Management withdrew a net $296M in Q4 2022, closing 28 positions and reducing 21 holdings. Its most notable exit was Palo Alto Networks, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 66% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in FIVE9 worth $6.45M.

  • Sphera Funds Management's largest Q4 2022 buy was FIVE9: 95,000 shares worth $6.45M.
  • Sphera Funds Management added most to CinCor Pharma, Inc. Common Stock in Q4 2022, an estimated $9.79M increase.
  • Sphera Funds Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $41.8M.
  • Sphera Funds Management fully exited Palo Alto Networks in Q4 2022, selling an estimated $10.3M.
  • Sphera Funds Management's ten largest holdings make up 57% of its $466M portfolio in Q4 2022.
  • Sphera Funds Management opened 18 new positions and closed 28 in Q4 2022.
  • Sphera Funds Management's portfolio value fell 35% quarter-over-quarter to $466M.

Based on Sphera Funds Management's 13F filing for Q4 2022, filed 14 Feb 2023.